Expertise

Dr. Fagan's research in pulmonary arterial hypertension revolves around several key projects all using animal models of PAH to better understand the pathophysiology of this fatal disease and identify potential new therapeutic targets. Dr. Fagan is also a clinician specializing in the treatment of patients with PAH at the University of South Alabama Pulmonary Hypertension Center. Current research projects including the role of inflammation in the pathogenesis of PAH, specifically the role of IL-6 more »

Past Affiliations
Communities
Internal Medicine, Pulmonary and Critical Care Medicine, Pharmacology
Degrees
MD, University of California, San Diego